Loading company…
neuroClues develops an eye-tracking medical device to help identify neurological disorders.
neuroClues develops a portable eye-tracking device for clinical assessment of eye movements, with data intended to support diagnosis and treatment planning for neurological disorders. Founded in 2020 by Pierre Daye, Pierre Pouget and Antoine Pouppez, the company is based in Louvain-la-Neuve, Belgium. In March 2026, it raised EUR 10 million in Series A funding co-led by Teampact Ventures, with White Fund, European Innovation Council, LeanSquare, Invest.BW and Wallonie Entreprendre participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in